The €76,600 grant will enable Dr Soldevila to develop her research line within the Clinical Research and Risk Factors for Neurodegenerative Diseases Group at the BBRC.
The book is leading reference on biomarkers shaping diagnosis, prognosis, and therapy development in Alzheimer’s disease and related dementias.
The GLYMPH-AD project, led by Dr Gonzalo Sánchez Benavides, will investigate the relationship between nocturnal blood pressure, the glymphatic system, loss of smell and the risk of developing Alzheimer’s disease.
Dr. Gemma Salvadó presented an oral communication at the 18th edition of the conference dedicated to clinical trials on Alzheimer's disease.
The Barcelonaβeta Brain Research Center (BBRC) and the Pasqual Maragall Foundation join DORA and CoARA, committing to a fairer and more inclusive research assessment that values quality and impact over traditional metrics.
Anna Soteras has been appointed Director of BBRC’s Clinical Operations Facility, where she will lead the co-ordination and delivery of the centre’s clinical studies.
These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time
MENOBRAIN will help uncover how menopause-related changes drive brain ageing and Alzheimer’s risk.
The ALFA10 study seeks to identify people at higher risk of developing Alzheimer's, even before the first symptoms appear